Home

Home

article image

Medison's Accuvix XQ Prestige 07 - a real-time 3D US scanner.

Improvement in staging of prostate cancer

Three-dimensional transrectal ultrasonography (3D-TRUS) allows accurate 3D examination of pathological structures and prediction of extracapsular tumor extension.

180 randomly selected patiens with initial diagnosed prostate cancer participated in a study at the Medical University of Innsbruck. Dr. Michael Mitterberger and colleagues used 3D-TRUS, which provides ultrasonograms in three planes simultaneously, for local staging of prostate cancer.

“3D-TRUS can be used with no problems and is a simple procedure allowing exact assessement for staging prostate cancer,” said Dr, Mitterberger. “Locally confined and locally advanced prostate cancer can be differentiated with maximum convenience, reliability, and ease.”
3D-TRUS highly increase chances to detect pathological capsular perforation of the tumor: It predicted 44 of 53 cases correctly and features an overall accuracy of 96%.

The investigators conclude their report in the July issue of BJU International: “3D-Trus can be considered to guide the decision before a planned radical prostatectomy. If 3D-TRUS indicated locally advanced disease, the probability of capsular perforation or seminal vesicle invasion is very high.”

This article was published on 08/05/2007

Search

 

Service

Company News

Technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.